Ivermectin

2025-2026 Bill 4042: Ivermectin - South Carolina Legislature Online

South Carolina General Assembly
126th Session, 2025-2026
Download
This Bill
in Microsoft Word Format
Indicates Matter Stricken
Indicates New Matter
H. 4042
STATUS INFORMATION
General Bill
Sponsors: Reps. Kilmartin, White, Gilreath, Cromer, Guffey, Harris, Hager, McCravy, Edgerton, Terribile, Magnuson, Lastinger, D. Mitchell, Sessions, Chapman, Brewer, Lawson, Oremus, Hartz, Vaughan, Pedalino, Teeple, Landing, Rankin, Schuessler, Ligon, Long, Sanders, Ford, T. Moore, Forrest, Chumley, Bowers, Taylor, Hixon, M.M. Smith, Gibson and Duncan
Companion/Similar bill(s): 3916
Document Path: LC-0176VR25.docx
Introduced in the House on February 19, 2025
Introduced in the Senate on May 6, 2026
Last Amended on May 13, 2026

Currently residing in the House
Summary: Ivermectin
HISTORY OF LEGISLATIVE ACTIONS

Date

Body

Action Description with journal page number

2/19/2025

House

Introduced and read first time (
House Journal-page 11
)

2/19/2025

House

Referred to Committee on
Medical, Military, Public and Municipal Affairs
(
House Journal-page 11
)

1/21/2026

House

Member(s) request name added as sponsor: Lastinger

2/4/2026

House

Member(s) request name added as sponsor: D. Mitchell

3/24/2026

House

Member(s) request name added as sponsor:
Sessions, Chapman, Brewer, Lawson, Oremus,
Hartz, Vaughan, Pedalino, Teeple, Landing,
Rankin, Schuessler, Ligon, Long, Sanders,
Ford, T. Moore

3/25/2026

House

Committee report: Favorable with amendment
Medical, Military, Public and Municipal Affairs
(
House Journal-page 4
)

3/26/2026

House

Member(s) request name added as sponsor: Forrest,
Chumley

3/26/2026

House

Requests for debate-Rep(s). Jones, Bamberg,
Kirby, Reese, Waters, MM Smith, Cobb-Hunter,
Henderson-Myers, Hart, Hosey, Williams, Luck,
King, JL Johnson, Grant (
House Journal-page 47
)

3/31/2026

House

Member(s) request name added as sponsor: Bowers

4/1/2026

House

Member(s) request name added as sponsor: Taylor, Hixon

4/1/2026

House

Debate adjourned until Thur., 4-2-26 (
House Journal-page 59
)

4/22/2026

House

Member(s) request name added as sponsor: M.M. Smith

4/23/2026

House

Debate adjourned (
House Journal-page 149
)

4/28/2026

House

Member(s) request name added as sponsor: Gibson

4/29/2026

House

Member(s) request name added as sponsor: Duncan

4/29/2026

House

Debate adjourned

5/5/2026

House

Amended (
House Journal-page 43
)

5/5/2026

House

Read second time (
House Journal-page 43
)

5/5/2026

House

Roll call Yeas-100 Nays-9 (
House Journal-page 44
)

5/6/2026

House

Read third time and sent to Senate (
House Journal-page 68
)

5/6/2026

Senate

Introduced and read first time

5/6/2026

Senate

Referred to Committee on
Medical Affairs
(
Senate Journal-page 6
)

5/6/2026

Senate

Polled out of committee
Medical Affairs
(
Senate Journal-page 8
)

5/6/2026

Senate

Committee report: Favorable
Medical Affairs
(
Senate Journal-page 8
)

5/12/2026

Senate

Special order, set for May 12, 2026 (
Senate Journal-page 59
)

5/13/2026

Senate

Amended (
Senate Journal-page 86
)

5/13/2026

Senate

Read second time (
Senate Journal-page 86
)

5/13/2026

Senate

Roll call Ayes-38 Nays-3

5/14/2026

Scrivener's error corrected

5/14/2026

Senate

Read third time and returned to House with amendments (
Senate Journal-page 108
)

5/15/2026

House

Debate adjourned (
House Journal-page 8
)

5/18/2026

House

Debate adjourned (
House Journal-page 5
)

View the latest
legislative information
at the website
VERSIONS OF THIS BILL
02/19/2025
03/25/2026
05/05/2026
05/06/2026
05/13/2026
05/14/2026

Indicates Matter Stricken

Indicates New Matter

Amended

May 13, 2026

H. 4042

Introduced by Reps. Kilmartin, White, Gilreath,
Cromer, Guffey, Harris, Hager, McCravy, Edgerton, Terribile, Magnuson,
Lastinger, D. Mitchell, Sessions, Chapman, Brewer, Lawson, Oremus, Hartz,
Vaughan, Pedalino, Teeple, Landing, Rankin, Schuessler, Ligon, Long, Sanders,
Ford, T. Moore, Forrest, Chumley, Bowers, Taylor, Hixon, M. M. Smith, Gibson
and Duncan

S. Printed 5/13/26--S. [SEC
5/14/2026 10:46 AM]

Read the first time May 6, 2026

________

A bill

TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ADDING SECTION
44-53-150
SO AS TO AUTHORIZE THE OVER-THE-COUNTER SALE OF IVERMECTIN TABLETS.

Amend Title To Conform

B
e it enacted by the
General Assembly of the State of South Carolina:

S
ECTION 1.
A
rticle 3, Chapter 53, Title 44 of the S.C. Code is
amended by adding:

S
ection
44-53-150
.
(
A) Notwithstanding any
provision of law to the contrary, FDA-approved ivermectin product labeled for
human use may be made available to the public for over-the-counter purchase in
this State to any person who is at least eighteen years of age, provided
ivermectin dispensed pursuant to this section must be maintained in an area
accessible only to pharmacy personnel. No prescription order shall be required
for such purchase.

(
B)
The Board of Pharmacy shall adopt rules to establish standard procedures for
the dispensing of ivermectin including the following:

(
1)
providing the patient with a screening risk assessment tool;

(
2)
providing the patient with information on the indications and contraindications
for the use of ivermectin, the appropriate method for using ivermectin, the
importance of medical follow-up, and any other information considered
appropriate by the department; and

(
3)
prohibitions on dispensing ivermectin when contraindications or clinically
significant drug interactions exist based on a patient's medication profile or
medical conditions.

(
C)
The Board of Pharmacy shall not require documentation beyond that reasonably
necessary to demonstrate compliance with this section and shall adopt rules
necessary to implement this section within ninety days of the effective date.

(
D) A
pharmacist may rely upon information provided by or on behalf of the patient
when acting pursuant to this section and is not liable for incomplete,
inaccurate, or omitted information provided by or on behalf of a patient. A
pharmacist acting in good faith and with reasonable care pursuant to this
section is immune from disciplinary or adverse administrative actions from the
Board of Pharmacy and is immune from civil liability in the absence of gross
negligence or wilful misconduct. A pharmacist shall be deemed to have acted
with reasonable care when acting in accordance with rules or procedures adopted
by the Board of Pharmacy pursuant to this section.

(
E) Nothing
in this section requires a pharmacist to:

(
1)
dispense ivermectin, when in the pharmacist's professional judgment, dispensing
may jeopardize the health or safety of the patient; or

(
2)
stock ivermectin.

(
F)
Nothing in this section shall be construed to require a health insurance issuer
to provide coverage for the cost of ivermectin dispensed pursuant to the
provisions of this section or to prevent a pharmacist from charging an
administrative or dispensing fee for the services provided pursuant to this
section.

S
ECTION 2. This act takes effect upon approval
by the Governor.

----XX----

This web page was last updated on May 14, 2026 at 10:47 AM